Cite
HARVARD Citation
Dill, V. et al. (2020). Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis. European journal of haematology. pp. 125-137. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dill, V. et al. (2020). Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis. European journal of haematology. pp. 125-137. [Online].